A LONG PERSPECTIVE ON A DIFFICULT PROBLEM: METABOLIC DYSFUNCTION AND STATOTIC LIVER DISEASE: A CORRELATIONAL STUDY

Abstract

An growing number of people at high risk are being affected by nonalcoholic fatty liver disease (NAFLD), which is becoming a bigger issue. The prevalence of nonalcoholic fatty liver disease exceeds 25% globally. Metabolic syndrome, a set of symptoms impacting the cardiovascular system and liver, is more likely to manifest. A comprehensive strategy is necessary for the treatment of NAFLD due to its complexity and the many comorbidities and challenges it often presents. When NAFLD is identified, many clinicians are unsure of how to proceed, the severity of the disorder, or the potential complications that may develop. Conditions like as cirrhosis, hepatocellular cancer, inflexible simple steatosis, and cardiovascular disease may lead to actively metabolising non-alcoholic steatosis (NASH). Due to differing views on the optimal methods of diagnosis and treatment, this might prove to be challenging. A study of NAFLD's history, diagnostic options, and treatment options is conducted by the researcher before any discussion of future possibilities for the development of multidisciplinary care routes is undertaken.